𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Early stage prostate cancer treated with radiation therapy: Stratifying an intermediate risk group

✍ Scribed by Joseph P. Lattanzi; Alexandra L. Hanlon; Gerald E. Hanks

Book ID
108435685
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
618 KB
Volume
38
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cancer-specific mortality after radiatio
Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancer
✍ Henry K. Tsai; Ming-Hui Chen; David G. McLeod; Peter R. Carroll; Jerome P. Richi πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 182 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. The presence of multiple determinants of aggressive cancer biology may impact prostate cancer‐specific mortality (PCSM) rates compared with fewer factors. The authors estimated PCSM after radiation therapy with short‐course androgen suppression therapy (RT+AST) or radica

Initial decline in hemoglobin during neo
Initial decline in hemoglobin during neoadjuvant hormonal therapy predicts for early prostate specific antigen failure following radiation and hormonal therapy for patients with intermediate and high-risk prostate cancer
✍ Anthony V. D'Amico; Tara Saegaert; Ming-Hui Chen; Andrew A. Renshaw; Daniel Geor πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Declines in serum hemoglobin (Hgb) levels occur from the use of androgen suppression therapy (AST) in the treatment of prostate cancer patients. We studied whether time to prostate specific antigen (PSA) failure following external beam radiation therapy (RT) and AST could